The transcription factor nuclear factor-kappa B (NF-κB) acts as an anti-apoptotic factor, therefore suppressing the NF-κB pathway has been utilized as a cancer treatment strategy (Monisha et al., 2017). The gene discussed is NFKB1; the disease is cancer.